Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 114, Issue 1, 2014, Pages 70-78

  Goto, Koji ^a   Nakai, Kentaro ^a   Shizuta, Satoshi ^a   Morimoto, Takeshi ^b   Shiomi, Hiroki ^a   Natsuaki, Masahiro ^a   Yahata, Mitsuhiko ^a   Ota, Chihiro ^a   Ono, Koh ^a   Makiyama, Takeru ^a   Nakagawa, Yoshihisa ^c   Furukawa, Yutaka ^d   Kadota, Kazushige ^e   Takatsu, Yoshiki ^f   Tamura, Takashi ^g   Takizawa, Akinori ^h   Inada, Tsukasa ⁱ   Doi, Osamu ^j   Nohara, Ryuji ^k   Matsuda, Mitsuo ^l   Takeda, Teruki ^m   Kato, Masayuki ⁿ   Shirotani, Manabu ^o   Eizawa, Hiroshi ^p   Ishii, Katsuhisa ^q   Lee, Jong Dae ^r   Takahashi, Masaaki ^s   Horie, Minoru ^t   Takahashi, Mamoru ^u   Miki, Shinji ^v   Aoyama, Takeshi ^w   Suwa, Satoru ^x   Hamasaki, Shuichi ^y   Ogawa, Hisao ^z   Mitsudo, Kazuaki ^e   Nobuyoshi, Masakiyo ^aa   Kita, Toru ^d   Kimura, Takeshi ^a   more..

^a KYOTO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c TENRI HOSPITAL   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e KURASHIKI CENTRAL HOSPITAL   (Japan)

^f HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^g JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^h SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

ⁱ OSAKA RED CROSS HOSPITAL   (Japan)

^j SHIZUOKA GENERAL HOSPITAL   (Japan)

^k Kitano Hospital   (Japan)

^l Kishiwada City Hospital   (Japan)

^m Koto Memorial Hospital   (Japan)

ⁿ Maizuru Kyosai Hospital   (Japan)

^o KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p NISHI KOBE MEDICAL CENTER   (Japan)

^q KANSAI ELECTRIC POWER CO   (Japan)

^r UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^s HAMAMATSU ROSAI HOSPITAL   (Japan)

^t SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^u Shimabara Hospital   (Japan)

^v MITSUBISHI KYOTO HOSPITAL   (Japan)

^w Shimada Municipal Hospital   (Japan)

^x JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^y KAGOSHIMA UNIVERSITY   (Japan)

^z KUMAMOTO UNIVERSITY   (Japan)

^aa KOKURA MEMORIAL HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT DURATION; VERY ELDERLY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; STROKE; TREATMENT OUTCOME;

EID: 84902142711     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.060     Document Type: Article

References (27)

1. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, K.J. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín European Society of Cardiology Working Group on Thrombosis Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 103 2010 13 28
2. S. Manzano-Fernández, F.J. Pastor, F. Marín, F. Cambronero, C. Caro, D.A. Pascual-Figal, I.P. Garrido, E. Pinar, M. Valdes, and G.Y. Lip Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting Chest 134 2008 559 567
3. R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, L. Mihalcsik, P. Mantovani, V. Sirbu, T.A. Bass, F. Della Rovere, A. Gavazzi, and D.J. Angiolillo Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy Am J Cardiol 102 2008 1618 1623
4. F. Gao, Y.J. Zhou, Z.J. Wang, H. Shen, X.L. Liu, B. Nie, Z.X. Yan, S.W. Yang, A. Jia de, and M. Yu Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation Circ J 74 2010 701 708
5. M. Lamberts, J.B. Olesen, M.H. Ruwald, C.M. Hansen, D. Karasoy, S.L. Kristensen, L. Kober, C. Torp-Pedersen, G.H. Gislason, and M.L. Hansen Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study Circulation 126 2012 1185 1193
6. M. Lamberts, G.H. Gislason, J.B. Olesen, S.L. Kristensen, A.M. Schjerning Olsen, A. Mikkelsen, C.B. Christensen, G.Y. Lip, L. Køber, C. Torp-Pedersen, and M.L. Hansen Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention J Am Coll Cardiol 62 2013 981 989
7. J.M. Ruiz-Nodar, F. Marin, V. Roldan, J. Valencia, S. Manzano-Fernandez, L. Caballero, J.A. Hurtado, F. Sogorb, M. Valdes, and G.Y. Lip Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv 5 2012 459 466
8. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
9. The GUSTO Investigators. An inter-national randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
10. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briët A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
11. S. Ogawa, Y. Aizawa, H. Atarashi, H. Inoue, S. Kamakura, Y. Koretsune, K. Kumagai, H. Mitamura, K. Okumura, K. Sugi, T. Yamashita, and M. Yasaka Guidelines for pharmacotherapy of atrial fibrillation Circ J 72 Suppl IV 2008 1639 1658 (in Japanese)
12. E.L. Eisenstein, K.J. Anstrom, D.F. Kong, L.K. Shaw, R.H. Tuttle, D.B. Mark, J.M. Kramer, R.A. Harrington, D.B. Matchar, D.E. Kandzari, E.D. Peterson, K.A. Schulman, and R.M. Califf Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 297 2007 159 168
13. M. Menozzi, A. Rubboli, A. Manari, R. De Palma, and R. Grilli Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis Thromb J 10 2012 22
14. R.G. Hart, O. Benavente, R. McBride, and L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
15. ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, M. Pfeffer, S. Hohnloser, and S. Yusuf Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
16. J.M. Ruiz-Nodar, F. Marin, J.A. Hurtado, J. Valencia, E. Pinar, J. Pineda, J.R. Gimeno, F. Sogorb, M. Valdes, and G.Y. Lip Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825
17. Y. Wan, C. Heneghan, R. Perera, N. Roberts, J. Hollowell, P. Glasziou, C. Bankhead, and Y. Xu Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Circ Cardiovasc Qual Outcomes 1 2008 84 91
18. H.C. Gwon, J.Y. Hahn, K.W. Park, Y.B. Song, I.H. Chae, D.S. Lim, K.R. Han, J.H. Choi, S.H. Choi, H.J. Kang, B.K. Koo, T. Ahn, J.H. Yoon, M.H. Jeong, T.J. Hong, W.Y. Chung, Y.J. Choi, S.H. Hur, H.M. Kwon, D.W. Jeon, B.O. Kim, S.H. Park, N.H. Lee, H.K. Jeon, Y. Jang, and H.S. Kim Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study Circulation 125 2012 505 513
19. M. Valgimigli, G. Campo, M. Monti, P. Vranckx, G. Percoco, C. Tumscitz, F. Castriota, F. Colombo, M. Tebaldi, G. Fuca, M. Kubbajeh, E. Cangiano, M. Minarelli, A. Scalone, C. Cavazza, A. Frangione, M. Borghesi, J. Marchesini, G. Parrinello, R. Ferrari Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
20. T. Tada, M. Natsuaki, T. Morimoto, Y. Furukawa, Y. Nakagawa, R.A. Byrne, A. Kastrati, K. Kadota, M. Iwabuchi, S. Shizuta, J. Tazaki, H. Shiomi, M. Abe, N. Ehara, T. Mizoguchi, H. Mitsuoka, T. Inada, M. Araki, S. Kaburagi, R. Taniguchi, H. Eizawa, A. Nakano, S. Suwa, A. Takizawa, R. Nohara, H. Fujiwara, K. Mitsudo, M. Nobuyoshi, T. Kita, T. Kimura CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2 Circ Cardiovasc Interv 5 2012 381 391
21. W.J. Dewilde, T. Oirbans, F.W. Verheugt, J.C. Kelder, B.J. De Smet, J.P. Herrman, T. Adriaenssens, M. Vrolix, A.A. Heestermans, M.M. Vis, J.G. Tijsen, A.W. van 't Hof, J.M. ten Berg WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
22. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, P. Kirchhof ESC Committee for Practice Guidelines (CPG) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
23. A.Y. Shen, J.F. Yao, S.S. Brar, M.B. Jorgensen, and W. Chen Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation J Am Coll Cardiol 50 2007 309 315
24. T. Yamaguchi Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group Stroke 31 2000 817 821
25. M. Yasaka, K. Minematsu, and T. Yamaguchi Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation Intern Med 40 2001 1183 1188
26. M. Hori, S.J. Connolly, J. Zhu, L.S. Liu, C.P. Lau, P. Pais, D. Xavier, S.S. Kim, R. Omar, A.L. Dans, R.S. Tan, J.H. Chen, S. Tanomsup, M. Watanabe, M. Koyanagi, M.D. Ezekowitz, P.A. Reilly, L. Wallentin, S. Yusuf RE-LY Investigators Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation Stroke 44 2013 1891 1896
27. M. Hori, M. Matsumoto, N. Tanahashi, S. Momomura, S. Uchiyama, S. Goto, T. Izumi, Y. Koretsune, M. Kajikawa, M. Kato, H. Ueda, K. Iwamoto, M. Tajiri J-ROCKET AF study investigators Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment Circ J 77 2013 632 638